RHUMBLINE ADVISERS - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,553,543
+5.9%
50,845
+8.9%
0.00%0.0%
Q2 2023$3,356,580
+123349.1%
46,710
+6.0%
0.00%
+33.3%
Q1 2023$2,719
-17.9%
44,077
+2.7%
0.00%
-25.0%
Q4 2022$3,312
-99.8%
42,939
+10.5%
0.00%
+33.3%
Q3 2022$1,734,000
+31.3%
38,856
+12.7%
0.00%
+50.0%
Q2 2022$1,321,000
+8.5%
34,484
+17.2%
0.00%0.0%
Q1 2022$1,218,000
+8.9%
29,421
-0.6%
0.00%
+100.0%
Q4 2021$1,118,000
+13.4%
29,586
-1.1%
0.00%0.0%
Q3 2021$986,000
-50.6%
29,930
+1.2%
0.00%
-66.7%
Q2 2021$1,994,000
+14.6%
29,564
-3.8%
0.00%
+50.0%
Q1 2021$1,740,000
-40.2%
30,732
-13.9%
0.00%
-50.0%
Q4 2020$2,908,000
+17.8%
35,700
+3.0%
0.00%0.0%
Q3 2020$2,469,000
-31.7%
34,659
-21.1%
0.00%
-33.3%
Q2 2020$3,614,000
+61.6%
43,919
+15.5%
0.01%
+20.0%
Q1 2020$2,237,000
-37.4%
38,031
+10.0%
0.01%
-16.7%
Q4 2019$3,574,000
+455.0%
34,576
+8.7%
0.01%
+500.0%
Q3 2019$644,000
-20.0%
31,799
+1.7%
0.00%
-50.0%
Q2 2019$805,000
+1418.9%
31,274
+128.5%
0.00%
Q1 2017$53,00013,6880.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 788,263$35,172,00044.43%
Fairmount Funds Management LLC 1,896,647$84,628,00014.88%
ACT CAPITAL MANAGEMENT, LLC 73,000$3,257,0004.50%
Ghost Tree Capital, LLC 300,000$13,386,0003.76%
Ikarian Capital, LLC 407,600$18,188,0003.62%
Paradigm Biocapital Advisors LP 520,080$23,206,0003.09%
MORGAN JESS S & CO INC 78,895$3,520,0003.06%
PFM Health Sciences, LP 1,659,733$74,057,0002.68%
RTW INVESTMENTS, LP 1,882,164$83,982,0001.94%
Ghost Tree Capital, LLC 150,000$6,693,0001.88%
View complete list of AXSOME THERAPEUTICS INC shareholders